You just read:

ICBII Announces the Filing of Orphan Drug Designation Application for the Use of α-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy

News provided by

Innovative California Biosciences International, Inc.

Dec 05, 2017, 17:02 EST